Ariadne Announces the Launch of Pathway Studio® Explore
April 14, 2010
Ariadne's Pathway Studio Explore Makes Visualizing Pathways Easy for Affymetrix GeneAtlas Personal Microarray System Ariadne announces the launch of Pathway Studio® Explore for the Affymetrix GeneAtlas™ Personal Microarray System. Ariadne's Pathway Studio Explore provides a biological context for the analysis of gene expression data to identify biological signal flow, key regulators, and affected pathways. Pathway [...]
New Pump Manifold Assembly Launched
April 14, 2010
The Uniqsis FlowSyn™ flow chemistry system is now available with an upgraded pump manifold assembly that offers several key advantages to the user: FlowSyn can automatically monitor each high pressure reagent channel and alert the user if a pump becomes air-locked or pumps inconsistently during an experiment. When used unattended, FlowSyn will abort the experiment [...]
Metrohm Presents the New Metrohm Suppressor Module «MSM-HC»
April 14, 2010
«MSM-HC» – Increased suppressor capacity for anion chromatography Metrohm presents the new Metrohm Suppressor Module «MSM-HC», a new high-capacity anion suppressor that is especially suitable for gradient applications with more highly concentrated carbonate or hydroxide eluents. Moreover, this new suppressor can be used for applications with isocratic hydroxide eluents. Because the eluting power of the [...]
Life Technologies Scientists Help Uncover Powerful Predictor of Breast Cancer Progression
April 14, 2010
New TaqMan Non-coding RNA Assays Enable Discovery of a Novel Molecular Regulator of Metastasis CARLSBAD, Calif.--Life Technologies Corporation (NASDAQ: LIFE) today announced that its scientists have teamed with researchers from Stanford University School of Medicine, and other institutions to discover a genomic component that plays a key role in promoting breast cancer progression. A study [...]
febit Receives European Union (EU) Patent for Synthesis of Minimal Genomes
April 14, 2010
LEXINGTON, Mass. (USA), and HEIDELBERG, Germany -– febit announced today the receipt of an EU patent, #EP 1 728 860B1, for its technology to synthesize minimal genomes. The new patent protects febit’s technology for combining genes to construct a minimal functional genome or parts of it. The EU patent complements earlier patents on the synthesis [...]
Five New Hospitals Order ValiMedTM MVS by CDEX to Protect Patients
April 14, 2010
TUCSON, AZ-- CDEX Inc. (OTCBB: CEXI) (www.cdexinc.com) announces it has received five orders for ValiMed™ Medication Validation Systems (MVS) from new hospital clients in states including Illinois, Pennsylvania, Florida, and Colorado. Studies worldwide continue to show high numbers of mistakes in the compounding of high-risk medications resulting in substantial harm to patients and economic loss [...]
Absorption Systems® Now Using the LTQ Orbitrap XL from Thermo Scientific
April 14, 2010
New technology enhances Absorption Systems’ metabolite identification capabilities EXTON, Pa.--Absorption Systems, a leader in testing drugs for ADMET (Absorption, Distribution, Metabolism, Excretion and Toxicity), announced today that the company has incorporated the LTQ Orbitrap XL Hybrid Fourier Transform mass spectrometer into its drug metabolism program. The introduction of the state-of-the-art technology enables more precise identification [...]
PerkinElmer Enters Into Agreement to Acquire Signature Genomic Laboratories, LLC
April 14, 2010
Acquisition brings new diagnostic services to global leader in pre-natal and newborn health screening WALTHAM, Mass.--PerkinElmer, Inc. (NYSE: PKI), a global leader focused on the health and safety of people and the environment, today announced that it has entered into a definitive agreement to acquire Signature Genomic Laboratories, LLC (Signature), a diagnostic genetic testing company [...]
Integrated DNA Technologies and Glycon Partner in Australia
April 14, 2010
CORALVILLE, Iowa and NEW SOUTH WALES, Australia -- Integrated DNA Technologies (IDT) and Glycon Pty Ltd of New South Wales, Australia, are partnering to bring IDT’s market leading products and services to researchers in Australia. IDT is among the world’s most respected manufacturers of custom synthetic oligonucleotides and genes. Glycon will offer Australia’s scientists local [...]
VisualSonics Announces Product Launch of VevoCQ(TM) Contrast Quantification Software
April 14, 2010
VevoCQ(TM) enables measurement of perfusion kinetics in tumors and other tissue TORONTO, April 14 -- VisualSonics Inc., the leader in real time, in vivo, high-resolution micro imaging systems, and Bracco Group, the foremost developer and manufacturer of ultrasound based contrast agents, today announced the launch of VevoCQ(TM) Advanced Quantification Software Tools for the Vevo(R) 2100 [...]

